Influence of psoriasis on work

Mattila, Kalle; Leino, Mauri; Mustonen, Anssi; Koulu, Leena; Tuominen, Risto

doi:10.1684/ejd.2013.1969

Cited by 16 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a previous study among the same patient population as in the current work [10], psoriasis was found to have a significant adverse effect on patients' work. The results in the current study confirm the findings of Sampogna et al that psoriasis has a significant influence on patients' everyday life, including leisure-time activities.…”

Section: Discussionmentioning

confidence: 51%

Perceived impact of psoriasis on leisure-time activities

Leino¹,

Mustonen²,

Mattila³

et al. 2014

European Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

Background: Psoriasis has an influence on various aspects of patients' everyday life. When estimating the total burden of the disease, the influence on leisure-time should also be taken into account. Objectives: To evaluate the perceived impact of psoriasis on leisure-time activities. Material and methods: The questionnaire study was based on 262 patients with psoriasis. The patients were asked to list their leisure-time activities, any activities they had reduced or given up completely because of psoriasis, the time spent on current leisure-time activities and the time they would have spent in a hypothetical situation if they did not have psoriasis. Using a visual analogue scale (VAS) of 0-100, the patients assessed how well they could currently perform their leisure-time activities and how well in a hypothetical situation without psoriasis. The difference between the VAS scores depicted the level of disadvantage caused by psoriasis. Results: More than half the patients (51.9%) had reduced or completely given up at least one leisure-time activity. The disadvantage score (VAS) of psoriasis was 16.9. Younger age was associated with higher disadvantage (r = 0.154, p<0.05). Sports activities were completely given up by 30.2% and reduced by 23.7%. Social activities and those which could be expected to cause embarrassment were given up by 29.0% and reduced by 21.4% of the patients. Conclusion: A majority of patients with psoriasis reduce or give up leisure-time activities because of their condition, so the influence of psoriasis on leisure-time is considerable.

show abstract

Section: Discussionmentioning

confidence: 51%

Perceived impact of psoriasis on leisure-time activities

Leino¹,

Mustonen²,

Mattila³

et al. 2014

European Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

show abstract

“…They were all diagnosed with moderate to severe psoriasis or psoriatic arthritis. The patient sample is described in detail by Mattila et al [14]. In the Finnish healthcare system patients with mild psoriasis are treated in primary health care settings and only moderate to severe cases are referred to tertiary level hospitals for further treatment.…”

Section: Methodsmentioning

confidence: 99%

Psoriasis Causes Significant Economic Burden to Patients

Mustonen

Mattila

Leino

et al. 2014

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

IntroductionPsoriasis results in expenses to patients from many cost sources. Psoriasis treatments may result in considerable time and traveling costs, yet many studies fail to account for these costs. The objective of this study was to evaluate the multidimensional economic burden of psoriasis to patients.MethodsThe study was based on 232 Finnish patients with psoriasis or psoriatic arthritis visiting a tertiary level dermatological clinic during a 1-year study period between October 1, 2009 and September 30, 2010. The data were based on a patient questionnaire, clinical data from the medical records and reimbursement data from the Finnish Social Insurance Institution. Item costs were based on true costs charged from the patients and all time cost estimates were based on the Human Capital Approach method.Results199 patients with psoriasis and 33 with psoriatic arthritis were included in the study. Total costs were higher for patients receiving traditional systemic medications or phototherapy than those not receiving such treatment. Travel costs and travel time costs accounted for more than 60% of the costs of phototherapy. Skin care at home was time consuming and thus caused significant burden to patients. The majority of the visit costs arose from hospital visits and only a small proportion were attributed to visiting primary health care providers.ConclusionVisit charges and other patient co-payments were estimated to play a minor role in the total cost of psoriasis incurred by patients, while travel costs and lost time comprised the majority of the costs, which should not be omitted in future studies regarding costs of treatments.Electronic supplementary materialThe online version of this article (doi:10.1007/s13555-014-0053-2) contains supplementary material, which is available to authorized users.

show abstract

“…A total of 262 patients completed the questionnaire (52.6% of the total study sample). Patients with Ps or PsA participated equally [21]. …”

Section: Methodsmentioning

confidence: 99%

The Costs of Psoriasis Medications

Mustonen

Mattila

Leino

et al. 2013

Dermatol Ther (Heidelb)

Self Cite

View full text Add to dashboard Cite

IntroductionPsoriasis is a chronic disease, which contributes to the economic burden on health care. The distribution of psoriasis medication costs and the quality of life in these patients has been estimated to be around 20% of total costs.ObjectivesTo estimate the economic distribution of medications and the impact of multiple treatment options on a patient’s quality of life.Materials and methodsThe study was based on 236 Finnish psoriasis patients. The Finnish Social Insurance Institution had databases for all psoriasis related medications purchased. Each purchase, during the 1-year study period (1 October 2009–30 September 2010), was recorded and analyzed. The dermatological quality-of-life index was collected from the medical records.ResultsTotal medication costs were €1,083 per year per patient. Topical treatments were the most often purchased medication and they comprised 18% of the total medication costs. Ten percent of the patients needed 3 or more medication changes during the 1-year study period. Biologics were used only by 5% of patients, but they produced 67% of total medication costs. Patients needing various treatments had higher medication costs and a poorer quality of life.ConclusionA small number of patients generated a great sum of medication costs partly due to the need to change medications. These patients had the worst quality-of-life index scores. Biologics formed a major cost component.Electronic supplementary materialThe online version of this article (doi:10.1007/s13555-013-0040-z) contains supplementary material, which is available to authorized users.

show abstract

Influence of psoriasis on work

Cited by 16 publications

References 0 publications

Perceived impact of psoriasis on leisure-time activities

Perceived impact of psoriasis on leisure-time activities

Psoriasis Causes Significant Economic Burden to Patients

The Costs of Psoriasis Medications

Contact Info

Product

Resources

About